XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Income (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Apr. 28, 2024
Apr. 30, 2023
Income Statement [Abstract]    
Net sales $ 206,105 $ 236,539
Cost of sales 104,232 122,738
Amortization of acquired technology 2,281 10,855
Total cost of sales 106,513 133,593
Gross profit 99,592 102,946
Operating expenses, net:    
Selling, general and administrative 52,269 57,780
Product development and engineering 41,604 50,601
Intangible amortization 307 4,882
Restructuring 2,269 1,563
Total operating expenses, net 96,449 114,826
Operating income (loss) 3,143 (11,880)
Interest expense (23,229) (20,510)
Interest income 542 1,069
Non-operating income (expense), net 400 (473)
Investment impairments and credit loss reserves, net (1,109) (33)
Loss before taxes and equity method income (loss) (20,253) (31,827)
Provision (benefit) for income taxes 2,956 (2,417)
Net loss before equity method income (loss) (23,209) (29,410)
Equity method income (loss) 50 (7)
Net loss (23,159) (29,417)
Net loss attributable to noncontrolling interest 0 (2)
Net loss attributable to common stockholders $ (23,159) $ (29,415)
Loss per share:    
Basic (in dollars per share) $ (0.36) $ (0.46)
Diluted (in dollars per share) $ (0.36) $ (0.46)
Weighted-average number of shares used in computing loss per share:    
Basic (in shares) 64,509 63,924
Diluted (in shares) 64,509 63,924